Browsing by Author "Bowlus, Christopher"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    The effects of elafibranor in people with primary biliary cholangitis: a plain language summary
    (Taylor and Francis Ltd., 2025) Kowdley, Kris V.; Bowlus, Christopher; Levy, Cynthia; Akarca, Ulus S.; Alvares-da-Silva, Mario Reis; Andreone, Pietro; Arrese, Marco; Francque, Sven M.; Heneghan, Michael A.; Invernizzi, Pietro; Jones, David; Lawitz, Eric; Mayo, Marlyn J.; Swain, Mark G.; Vargas, Victor; Vierling, John M.; Villamil, Alejandra; Addy, Carol; Dietrich, Julie; Mazain, Sarah; Taddé, Bachirou; Miller, Benjamin; Shu, Jianfen; Zein, Claudia O.; Roberts, Carol; Wright, Gail; Schattenberg, Jörn M.
    This is a plain language summary describing the phase 3 clinical trialcalled ‘ELATIVE®’. Primary biliary cholangitis (PBC) is a rare disease of the liverthat can get worse over time and can be potentially life threatening. Livingwith PBC can also reduce a person’s quality of life. There are currently notmany treatment options available for PBC. The ELATIVE® clinical trial testedhow well a potential new treatment called ‘elafibranor’ works in treatingpeople with PBC.